Adherencia al tratamiento en pacientes con hipertensión: una Revisión Sistemática

Autores/as

DOI: https://doi.org/10.6018/eglobal.684121
Palabras clave: Hipertensión, Adherencia al tratamiento, Presión arterial, Antihipertensivos, Revisión sistemática

Resumen

Introducción: La adherencia al tratamiento farmacológico desempeña un papel fundamental en el manejo eficaz de la hipertensión. Diversos factores contribuyen a la discrepancia entre los objetivos de control de la hipertensión a nivel poblacional y las tasas reales de control.

Objetivo: identificar y evaluar los factores asociados con la adherencia al tratamiento farmacológico en pacientes con hipertensión.

Material y método: Directrices de los Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020. Se realizaron búsquedas exhaustivas de literatura en bases de datos de acceso abierto como PubMed, ScienceDirect, Wiley Online Library y ProQuest.

Resultados: La búsqueda inicial en las bases de datos arrojó 1.658 artículos, de los cuales 29 estudios cumplieron con los criterios de inclusión después de la selección. Los factores identificados que influyen en la adherencia al tratamiento farmacológico se clasificaron en cuatro categorías: factores internos individuales, relacionados con los centros de salud, con los medicamentos y clínicos. Entre ellos, los factores internos individuales resultaron ser la categoría más predominante. Sin embargo, existen interconexiones significativas entre los factores de las diferentes categorías, que en conjunto pueden afectar la adherencia de los pacientes hipertensos a sus regímenes terapéuticos prescritos.

Conclusiones: se identificó que los factores que influyen en la adherencia al tratamiento farmacológico en pacientes con hipertensión pueden clasificarse en factores internos individuales, relacionados con los centros de salud, con los medicamentos y factores clínicos. No obstante, no fue posible determinar de manera concluyente cuáles de estos factores contribuyen de forma más significativa a la falta de adherencia.

Descargas

Los datos de descargas todavía no están disponibles.
Metrics
Vistas/Descargas
  • Resumen
    0
  • ESP_PDF
    0
  • ENG_PDF
    0
  • XML
    0

Citas

1. Sudayasa IP, Husdaningsih F, Alifariki LO. Polymorphism of Gene ACE I/D and Family History of Hypertension as Predisposition of Hypertension. Malaysian Journal of Medicine & Health Sciences. 2023;19(3). DOI: https://doi.org/10.47836/mjmhs19.3.22

2. Religioni U, Barrios-Rodríguez R, Requena P, Borowska M, Ostrowski J. Enhancing therapy adherence: impact on clinical outcomes, healthcare costs, and patient quality of life. Medicina (B Aires). 2025;61(1):153. DOI:10.3390/medicina6100153

3. Uchmanowicz B, Chudiak A, Uchmanowicz I, Rosińczuk J, Froelicher ES. Factors influencing adherence to treatment in older adults with hypertension. Clin Interv Aging. 2018; 13:2425–41. DOI: 10.2147/CIA.S182881

4. Bekker CL, Aslani P, Chen TF. The use of medication adherence guidelines in medication taking behaviour research. Research in Social and Administrative Pharmacy [Internet]. 2022;18(2):2325–30. DOI: 10.1016/j.sapharm.2021.10.012

5. Choudhry NK, Kronish IM, Vongpatanasin W, Ferdinand KC, Pavlik VN, Egan BM, et al. Medication Adherence and Blood Pressure Control: A Scientific Statement from the American Heart Association. Hypertension [Internet]. 2022 Jan 1;79(1): e1–14. Available from: https://doi.org/10.1161/HYP.0000000000000203

6. Burnier M, Egan BM. Adherence in Hypertension. Circ Res [Internet]. 2019 Mar 29;124(7):1124–40. Available from: https://doi.org/10.1161/CIRCRESAHA.118.313220

7. Kvarnström K, Westerholm A, Airaksinen M, Liira H. Factors contributing to medication adherence in patients with a chronic condition: A scoping review of qualitative research. Vol. 13, Pharmaceutics. MDPI AG; 2021. DOI: 10.3390/pharmaceutics13040450

8. Carey RM, Wright JT, Taler SJ, Whelton PK. Guideline-Driven Management of Hypertension. Circ Res [Internet]. 2021 Apr 2;128(7):827–46. Available from: https://doi.org/10.1161/CIRCRESAHA.121.318083

9. Berardinelli D, Conti A, Hasnaoui A, Casabona E, Martin B, Campagna S, et al. Nurse-Led Interventions for Improving Medication Adherence in Chronic Diseases: A Systematic Review. Vol. 12, Healthcare (Switzerland). Multidisciplinary Digital Publishing Institute (MDPI); 2024. DOI: 10.3390/healthcare12040471

10. Ruswati R. The Role of Nurses in Enhancing Medication Adherence and Patient Outcomes in Hypertension Management. International Journal of Nursing and Midwifery Research. 2024 Jul;2(3):78–87. DOI: https://doi.org/10.35335/ners.v2i3.286

11. Abbas H, Kurdi M, de Vries F, van Onzenoort HAW, Driessen JHM, Watfa M, et al. Factors Associated with Antihypertensive Medication Non-Adherence: A Cross-Sectional Study Among Lebanese Hypertensive Adults. Patient Prefer Adherence [Internet]. 2020 Apr 1;14(null):663–73. DOI: 10.2147/PPA.S238751

12. Chen Y, Gao J, Lu M. Medication adherence trajectory of patients with chronic diseases and its influencing factors: A systematic review. J Adv Nurs. 2023 Jan 5;80(1):11–41. DOI: 10.1111/jan.15740

13. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. International Journal of Surgery. 2021; 88:105906. DOI: 10.1016/j.ijsu.2021.105906

14. Abel WM, Efird JT. The association between trust in health care providers and medication adherence among Black women with hypertension. Front Public Health. 2013;(DEC). DOI: 10.3389/fpubh.2013.00078

15. Baggarly SA, Kemp RJ, Wang X, Magoun AD. Factors associated with medication adherence and persistence of treatment for hypertension in a Medicaid population. Research in Social and Administrative Pharmacy. 2014;10(6): e99-112. DOI: 10.1016/j.sapharm.2014.02.005

16. Kressin NR, Wang F, Long J, Bokhour BG, Orner MB, Rothendler J, et al. Hypertensive patients’ race, health beliefs, process of care, and medication adherence. J Gen Intern Med. 2007;22(6):768–74. DOI: 10.1007/s11606-007-0175-3

17. Lor M, Koleck TA, Bakken S, Yoon S, Dunn Navarra AM. Association between health literacy and medication adherence among hispanics with hypertension. J Racial Ethn Health Disparities. 2019; 6:517–24. DOI: 10.1007/s40615-018-0481-6

18. Patel RP, Taylor SD. Factors Affecting Medication Adherence in Hypertensive Patients. Ann Pharmacother. 2002; 36:40–4. DOI: 10.1345/aph.1A066

19. Rajpura J. Medication Adherence in a Sample of Elderly Suffering from Hypertension: Evaluating the Influence of Illness Perceptions, Treatment Beliefs, and Illness Burden. Journal of Managed Care Pharmacy. 2014;20(1):58–65. DOI: 10.18553/jmcp.2014.20.1.58

20. Roumie CL, Greevy R, Wallston KA, Elasy TA, Kaltenbach L, Kotter K, et al. Patient centered primary care is associated with patient hypertension medication adherence. J Behav Med. 2011;34(4):244–53. DOI: 10.1007/s10865-010-9306-1

21. Lo SHS, Chau JPC, Woo J, Thompson DR, Choi KC. Adherence to antihypertensive medication in older adults with hypertension. Journal of Cardiovascular Nursing. 2016;31(4):296–303. DOI: 10.1097/JCN.0000000000000264

22. Li WTL, Kang CD, Tsang PPM, Wang HHX, Liu KQL, Chan WM, et al. Determinants of medication adherence and blood pressure control among hypertensive patients in Hong Kong: A cross-sectional study. Int J Cardiol. 2015; 182:250–7. DOI: 10.1016/j.ijcard.2015.01.049

23. Ma C. A cross-sectional survey of medication adherence and associated factors for rural patients with hypertension. Applied Nursing Research. 2016; 31:94–9. DOI: 10.1016/j.apnr.2016.01.004

24. Shi S, Shen Z, Duan Y, Ding S, Zhong Z. Association between medication literacy and medication adherence among patients with hypertension. Front Pharmacol. 2019; 10:822. DOI: 10.3389/fphar.2019.00822

25. Wang W, Lau Y, Loo A, Chow A, Thompson DR. Medication adherence and its associated factors among Chinese community-dwelling older adults with hypertension. Heart and Lung: Journal of Acute and Critical Care. 2014;43(4):278–83. DOI: 10.1016/j.hrtlng.2014.03.004

26. Bhusal A, Jadhav P, Deshmukh Y. Assessment of medication adherence among hypertensive patients: a cross-sectional study. Int J Basic Clin Pharmacol. 2016;1606–12. DOI: https://doi.org/10.18203/2319-2003.ijbcp20162480

27. Thomas D, Meera NK, Binny K, Sekhar MS, Kishore G, Sasidharan S. Medication adherence and associated barriers in hypertension management in India. CVD Prev Control. 2011 Jan;6(1):9–13. DOI: 10.1016/j.cvdpc.2011.01.002

28. Rahmawati R, Bajorek B. Factors affecting self-reported medication adherence and hypertension knowledge: A cross-sectional study in rural villages, Yogyakarta Province, Indonesia. Chronic Illn. 2018;14(3):212–27. DOI: 10.1177/1742395317710313

29. Alfian SD, Annisa N, Perwitasari DA, Coelho A, Abdulah R. The role of illness perceptions on medication nonadherence among patients with hypertension: A multicenter study in indonesia. Front Pharmacol. 2022;13. DOI: 10.3389/fphar.2022.870429

30. Kamran A, Ahari SS, Biria M, Malepour A, Heydari H. Determinants of Patient’s Adherence to Hypertension Medications: Application of Health Belief Model Among Rural Patients. Ann Med Health Sci Res. 2015;4(6):922–7. DOI: 10.4103/2141-9248.149779

31. Mahmoudian A, Zamani A, Tavakoli N, Farajzadegan Z, Fathollahi-Dehkordi F. Medication adherence in patients with hypertension: Does satisfaction with doctor-patient relationship work? Journal of Research in Medical Sciences. 2017;22. DOI: 10.4103/1735-1995.200277

32. Jankowska-Polańska B, Uchmanowicz I, Dudek K, Mazur G. Relationship between patients’ knowledge and medication adherence among patients with hypertension. Patient Prefer Adherence. 2016; 10:2437–47. DOI: 10.2147/PPA.S119994

33. Karakurt P, Kaşikçi M. Factors affecting medication adherence in patients with hypertension. Journal of Vascular Nursing. 2012;30(4):118–26. DOI: 10.1016/j.jvn.2012.06.001

34. Boratas S, Kilic HF. Evaluation of medication adherence in hypertensive patients and influential factors. Pak J Med Sci. 2018;34(4):959–63. DOI: 10.12669/pjms.344.14924

35. Durand H, Hayes P, Harhen B, Conneely A, Finn DP, Casey M, et al. Medication adherence for resistant hypertension: Assessing theoretical predictors of adherence using direct and indirect adherence measures. Br J Health Psychol. 2018;23(4):949–66. DOI: 10.1111/bjhp.12326

36. Ramli A, Ahmad NS, Paraidathathu T. Medication adherence among hypertensive patients of primary health clinics in Malaysia. Patient Prefer Adherence. 2012; 6:613–22. DOI: 10.2147/PPA.S34750

37. Nakwafila O, Mashamba-Thompson T, Godi A, Sartorius B. A Cross-Sectional Study on Hypertension Medication Adherence in a High-Burden Region in Namibia: Exploring Hypertension Interventions and Validation of the Namibia Hill-Bone Compliance Scale. Int J Environ Res Public Health. 2022;19(7). DOI: 10.3390/ijerph19074233

38. Al-Noumani H, Wu JR, Barksdale D, Knafl G, Alkhasawneh E, Sherwood G. Health beliefs and medication adherence in omanis with hypertension. Journal of Cardiovascular Nursing. 2018;33(6):518–26. DOI: 10.1097/JCN.0000000000000492

39. Park YH, Kim H, Jang SN, Koh CK. Predictors of adherence to medication in older Korean patients with hypertension. European Journal of Cardiovascular Nursing. 2013;12(1):17–24. DOI: 10.1177/1474515112438452

40. Khan MU, Shah S, Hameed T. Barriers to and determinants of medication adherence among hypertensive patients attended National Health Service Hospital, Sunderland. J Pharm Bioallied Sci. 2014;6(2):104–8. DOI: 10.4103/0975-7406.129170

41. Thuy LT, Monkong S, Pookboonmee R, Leelacharas S, Viwatwongkasem C. Factors Explaining Medication Adherence of Older Adults with Hypertension: A Cross-sectional Study. Pac Rim Int J Nurs Res Thail. 2020;24(3): https://he02.tci-thaijo.org/index.php/PRIJNR/artic

42. Thomas D, Meera NK, Binny K, Sekhar MS, Kishore G, Sasidharan S. Medication adherence and associated barriers in hypertension management in India. CVD Prev Control. 2011;6(1):9–13. DOI: 10.1016/j.cvdpc.2010.11.001

43. Kardas P, Almada M, Malo S, Midão L, Vrijens B, Aguilar-Palacio I, et al. The need for patient adherence standard measures for Big Data. 2020; DOI: 10.2196/18150

44. García-Ovejero E, Pisano-González M, Salcedo-Diego I, Serrano-Gallardo P. Impact of Chronic Disease Self-Management Program on the Self-Perceived Health of People in Areas of Social Vulnerability in Asturias, Spain. Healthcare (Switzerland). 2024 Apr 1;12(8). DOI: 10.3390/healthcare12080918

45. Karakurt, Papatya; Bilgin, Sonay; Özdemir, Selen. Association between health literacy and medication adherence in patients with hypertension: a cross-sectional study. Scientific Reports, 2025. DOI: https://doi.org/10.1038/s41598-025-30399-2

46. Guo, Aizhen, et al. Impact of health literacy and social support on medication adherence in patients with hypertension: a cross-sectional community-based study. BMC Cardiovascular Disorders, 2023, 23.1: 93. DOI: 10.1186/s12872-023-03193-0

47. Kim, Dayea; Cha, Jaewoo. Association between medical complications according to continuity of care and medication adherence in patients with hypertension in Korea: a national population-based cohort study. BMJ open, 2023, 13.6: e073404. DOI: 10.1136/bmjopen-2023-073404

48. Ljungholm L, Klinga C, Edin-Liljegren A, Ekstedt M. What matters in care continuity on the chronic care trajectory for patients and family carers?. A conceptual model. J Clin Nurs. 2022 May 1;31(9–10):1327–38. DOI: 10.1111/jocn.16074

49. Spencer J, Bahuguna M, Ramani S, Pathak S, Shende S, Pantvaidya S, et al. What constitutes ‘poor’ adherence to medical advice for chronic diseases? Insights from a qualitative study among hypertension and diabetes patients in urban informal settlements, Mumbai Metropolitan Region. PLoS One [Internet]. 2025 Nov 18;20(11): e0324765-. Available from: https://doi.org/10.1371/journal.pone.0324765

50. Burnier M. The role of adherence in patients with chronic diseases. Eur J Intern Med [Internet]. 2024; 119:1–5. DOI: 10.1016/j.ejim.2023.10.012

51. Adeyemi AH, Wiredu B, Okobi OE, Nebuwa P, Ezeani EI, Alozie AS. Challenges and Strategies in Medication Management for Patients with Multiple Comorbidities. Cureus. 2025 jun 14; DOI: 10.7759/cureus.85992

52. Yazie TS, Mengistu WE, Yimer YS, Dagnew SB, Dagnew FN, Moges TA, et al. Clinical factors associated with multimorbidity, polypharmacy and medication regimen complexity among adults with hypertension: a multicentre cross-sectional study. BMJ Open [Internet]. 2025 Apr 1;15(4): e091997. DOI: 10.1136/bmjopen-2024-091997

Publicado
09-07-2026
Cómo citar
[1]
Riki, L.O.A. et al. 2026. Adherencia al tratamiento en pacientes con hipertensión: una Revisión Sistemática. Enfermería Global. 25, 2 (jul. 2026). DOI:https://doi.org/10.6018/eglobal.684121.
Número
Sección
Revisiones